華信新材(300717.SZ)獲國家知識產權局頒發4項發明專利證書
格隆匯12月25日丨華信新材(300717.SZ)發佈公告,公司在2019年期間收到國家知識產權局頒發4項發明專利證書,專利名稱包括“PETG/PET/PETG共擠膜片及其擠出成型工藝”;“可降解水性聚氨脂及其製備方法和應用”;“用於數碼打印膠片的PET片材及其製備方法”;及“一種PET醫用打印基片及其生產工藝”。
公告表示,上述專利的取得不會對公司目前生產經營情況產生重大影響,但在一定程度上有利於發揮公司的自主知識產權優勢,完善知識產權保護體系,促進技術創新,提升公司的競爭能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.